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Abstract
In 2010, the G8 placed renewed focus on maternal health via the Muskoka Initiative by committing to spend an additional
$5 billion on maternal, newborn, and child health before 2015. Following the end of the Millennium Development Goals
and the advent of the Sustainable Development Goals, maternal health issues have continued to feature prominently on
the global health agenda. Despite these substantial investments of foreign aid over the past decade, there is limited ev-
idence on the effectiveness of foreign aid in reducing maternal mortality in low- and middle-income countries (LMICs).
Using data from the Organisation for Economic Cooperation and Development, the World Development Indicators and
the Institute of Health Metrics and Evaluation, this study analyzes the effects of aid on maternal health in a sample of
130 LMICs from 1996 through 2015. Our results show that the effects of total foreign aid on maternal mortality are lim-
ited, but that aid allocated to the reproductive health sector and directly at maternal health is associated with significant
reductions in maternal mortality. Given these targeted effects, it is important to channel more donor assistance to the
promotion of reproductive health and contraceptive use among women as it serves as a tool towards the reduction of
maternal mortality.
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1. Introduction
Recent debates concerning the effectiveness of aid in
improving development outcomes have been inconclu-
sive (Tilburg, 2015). Aid critics (Easterly, 2006; Moyo,
2009; Winters, 2010) have voiced their concerns that
aid is “dead”. They maintain that billions of dollars have
been transferred to poor economies with the aim of im-
proving living conditions, but the results have always
been catastrophic, leaving more than a billion people
still living in abject poverty. Despite these concerted ef-
forts, there has been limited academic research on the
links between foreign aid and maternal mortality reduc-
tion in low- and middle-income countries (LMICs; Taylor,
Hayman, Crawford, Jeffery, & Smith, 2013).
In the case aid committed to maternal health, the
Muskoka Initiative on Maternal, Newborn and Child
Health was one such commitment adopted at the G8
summit in 2010. This initiative saw a commitment of
$7.3 billion through 2015 to improve maternal and child
health in the world’s poorest countries and to contribute
to the achievement of Goal 5 of theMillennium Develop-
ment Goals (MDGs). The presumption that aid can com-
bat maternal mortality, however, seemed to be based
on limited evidence, and this relationship has rarely fea-
tured in the global health research agenda.
Given the Muskoka commitments, and support for
the MDGs and Sustainable Development Goals (SDGs),
over the past decade, the donor community has com-
mitted sizeable financial resources to the reduction of
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maternal deaths in developing countries. Between 1990
and 2017 and estimated $11.6 billion has been invested
in maternal health (Institute of Health Metrics and
Evaluation [IHME], 2018). Yet, high levels of maternal
mortality are still prevalent in many parts of the world.
It is estimated that in 2015 99% (302,000) of maternal
deaths were recorded in LMICs compared to other de-
veloped regions of the world (World Health Organization
[WHO], UNICEF, UNFPA, & TheWorld Bank, 2015). Given
the seeming role for international development assis-
tance in combatting this development challenge, it is im-
portant to assess the evidence of aid’s efficacy in reduc-
ing maternal mortality. As such, this study examines the
effect of foreign aid onmaternal mortality in LMICs using
two-way fixed effects panel regression over the period
from 1996 through 2015.
2. Background
Evidence suggests most LMICs were not able tomeet the
targets of the health-relatedMDGs of reducing maternal
mortality ratio by 75% between 1990 and 2015 (WHO
et al., 2015). Indeed, by 2015, theWHO reported an esti-
mateddecline in globalmaternalmortality rate (MMR) of
45% in that period to 210 deaths per 100,0000 live births,
far short of the 75% reduction goal. Following theMDGs,
the SDGs set a target of loweringMMR to 70 per 100,000
live births, as part of SDG 3’s goal to “ensure healthy lives
and promote wellbeing for all at all ages”. To this end,
several donor countries have pledged their support to in-
crease funding towards the reduction of maternal health
levels to the countries with the poorest health indicators
(Proulx, Ruckert, & Labonté, 2017).
Previous foreign aid research has mainly focused
on economic development and poverty reduction with
mixed results. For example, Bornschier, Chase-Dunn and
Robinson (1978), Dalgaard, Hansen and Tarp (2004), and
Arndt, Jones and Tarp (2015) all show that foreign aid
has a positive impact on economic growth. In contrast,
Durbarry, Gemmel and Greenaway (1998), and Annen
and Kosempel (2009) and Easterly (2003) show that for-
eign aid has no impact on economic growth. Ekanayake,
Cookman and Chatrna’s (2000) study on the effect of for-
eign aid in developing countries show that there is no
impact. Given the complex relationship between health
and development, there is an interest in exploring how
investments in people’s overall health in a country con-
tribute to economic development. It is argued that if the
productive workforce is healthy, they can work meaning-
fully towards higher productivity translating into a higher
economic growth and development.
While these studies provide an important step in ob-
taining empirical evidence of the role of foreign aid on
development outcomes, few studies to date have ex-
amined the impact of foreign aid on health outcomes
such as mortality (Kotsadam, Østby, Rustad, Tollefsen, &
Urdal, 2018). Early studies point to a harmful effect of
aid on mortality and health outcomes, specifically in the
case where aid increased the indebtedness of recipient
countries (Bradshaw, Noonan, Gash, & Sershen, 1993;
Sell & Kunitz, 1986). Shen and Williamson (1999) find
that greater indebtedness—in some cases aid-related—
indirectly increases maternal mortality, but conclude
their study with a rallying call to donors, arguing: “It is
likely that even a modest increase in aid could substan-
tially improve maternal mortality rates if it were spent
on improving the access of poor women to health ser-
vices” (p. 211).
More recent studies on the impact of foreign aid on
mortality have mainly focused on infant or child mortal-
ity (Burguet & Soto, 2012; Kotsadam et al., 2018; Mishra
& Newhouse, 2009; Pandolfelli, Shandra, & Tyagi, 2014;
Winkleman&Adams, 2017). Similarly to the economic lit-
erature, empirical evidence suggests that the effects of
foreign aid on mortality are inconclusive. Many studies
highlight the inefficacy or negative effects of aid. For ex-
ample, Williamson (2008) find that foreign aid is ineffec-
tive in improving overall health. Likewise, Pandolfelli et al.
(2014) find that International Monetary Fund loans and
structural adjustment contribute to highermaternalmor-
tality in Sub-Saharan Africa. These deleterious effects of
structural adjustment on child and maternal mortality
are echoed by Thomson, Kentikelenis and Stubbs (2017),
Powell-Johnson, Borghi, Mueller, Patouillard and Mills
(2006) also find a positive relationship between mortal-
ity and Official Development Assistance (ODA). Other re-
search is mixed: Mishra and Newhouse (2009) show that
total overall aid had no impact on infant mortality, while
health aid reduced mortality levels. Still other studies
find beneficial effects of aid onmortality rates: Kotsadam
et al. (2018) show that aid programming reduces infant
mortality for marginalized communities, while Yogo and
Mallaye (2015) demonstrate that increased health aid is
linked to significant decreases in child mortality.
While few studies have touched on aid’s effect on
maternal mortality, there has been a concerted effort
to track aid spending in this area. Greco, Powell-Jackson,
Borghi andMills (2008) tracked the flowof health-related
aid from 2003 through 2006 and found that aid to mater-
nal health did not always go to the most affected coun-
tries. This tracking was part of a series of Lancet articles
whichmapped ODA spending onmaternal health but did
not analyze its effects on maternal mortality (Arregoces
et al., 2015; Grollman et al., 2017; Hsu, Pitt, Greco,
Berman, & Mills, 2012; Powell-Johnson et al., 2006).
These studies provide a strong basis upon which to ex-
amine the effects of the flow of aid to maternal health.
Considering the significant international attention
paid to the maternal mortality issue by the international
community and donor agencies in recent years, the rel-
ative absence of empirical evidence linking aid and re-
duced mortality is surprising. This study aims to provide
some of this evidence and examine the impact of several
categories of foreign aid spending on maternal mortality
over time. This evidence is important, not only to bet-
ter understand the health effects of aid, but also to ex-
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pand the growing literatures linking aid to gender equal-
ity outcomes (Grown, Addison, & Tarp, 2016; Pickbourn
& Ndikumana, 2016; Tiessen, 2015).
3. Data and Methods
3.1. Data
Data for this study are drawn from the Organisation for
Economic Cooperation and Development (OECD) Credi-
tor Reporting System (CRS) database, the World Devel-
opment Indicators (WDI) from theWorld Bank, the IHME
database, and Grollman et al.’s (2017) ODA+ data set on
aid to maternal health.
Our main sample consists of 130 LMICs that were el-
igible to receive the various categories of aid between
1996 and 2015. In total, the sample consists of 2,093
country-year observations over that period for which all
data was available. Descriptive statistics for our sample
are shown in Table 1.
The dependent variable in this study is MMR: the
number ofmaternal deaths in a given period per 100,000
women of reproductive age during the same time pe-
riod (WHO, UNICEF, UNFPA, & The World Bank, 2012).
We test the relationship between aid and MMR using
two different data sources for the dependent variable.
TheMMRmeasure in our main analysis consists of MMR
data from the WHO and housed in the World Bank’s
WDI dataset. As a robustness check, we also repeat
our analysis using MMR data from the IHME “Maternal
Mortality Estimates and MDG 5 Attainment by Country
1990–2011” dataset (IHME, 2011). TheWHO defines ma-
ternal death as:
The death of a woman while pregnant or within 42
days of termination of pregnancy, irrespective of the
duration and site of pregnancy from any cause related
to or aggravated by the pregnancy or its management
but not from accidental or incidental causes. (WHO
ICD-10, 2011, p. 156)
The causes of maternal death according to the WHO
can be direct or indirect causes. The direct causes are
those resulting from complications of the pregnant state,
from interventions, omissions, incorrect treatment, or
from a chain of events resulting from any of the above.
Table 1. Sample descriptive statistics, 130 countries, 1996–2015.
Min Mean Median Max SD N Source
Dependent variable
Maternal mortality ratio (MMR)—primary 4.00 289.32 148.00 2650.00 321.69 2093 WDI
analysis
Maternal mortality ratio (MMR)—robustness 6.80 294.00 113.50 2592.50 335.29 1709 IHME
analysis
Aid measures (per capita)
Total aid (constant 2011 USD) 0.00 68.66 39.95 1257.09 98.73 2093 OECD CRS
Total aid to Health (constant 2011 USD) 0.00 4.14 1.57 170.19 8.94 2093 OECD CRS
Total population/reproductive policy and 0.00 2.87 0.80 133.76 7.56 2093 OECD CRS
programming (constant 2011 USD)
Aid to reproductive health 0.00 0.34 0.09 11.83 0.76 2093 OECD CRS
(constant 2011 USD)
Aid to family planning (constant 2011 USD) 0.00 0.16 0.00 5.75 0.41 2093 OECD CRS
Total maternal and newborn health aid 0.00 0.57 0.09 12.36 1.10 2093 Grollman
(constant 2013 USD) et al., 2017
Controls
GDP per capita, (constant 2010 USD) 186.66 5414.95 2357.40 72670.96 9666.15 2093 WDI
Births attended by skilled health personnel, 5.60 72.28 81.00 100.00 27.06 2093 WDI
percentage, percent
Adolescent fertility rate (births per 3.82 72.17 63.98 218.77 47.62 2093 WDI
1,000 women ages 15–19)
Contraceptive prevalence, modern methods 1.20 35.76 34.50 86.20 20.92 2093 WDI
(percent of women ages 15–49)
Instrument
Donor fractionalization-recipient aid 0 0.22 0.25 0.38 0.08 2055 OECD/
probability interaction WB DPI
Politics and Governance, 2019, Volume 7, Issue 2, Pages 53–67 55
The indirect causes are those not due to direct obstet-
ric causes. Not surprisingly, there is a close association
between economic development in a country and its
rates of maternal mortality. Figure 1 highlights this re-
lationship for our sample countries in 2015, showing
that wealthier countries are likely to have lower rates
of mortality. Mean MMR in our sample is approximately
289 deaths per 100,000 women, while median MMR is
approximately 148. MMR varies significantly across dif-
ferent geographic regions within our sample and over
time. Figure 2 shows this variability, revealing that over-
allMMRhas declined significantly over time, but remains
high in certain regions.
Our main independent variables are the annual ODA
flows for six categories of aid in millions of constant 2011
USD. The source from the OECD is the net bilateral ODA
commitments by the Development Assistance Commit-
tee (DAC) donors reported from the CRS. This study con-
siders all forms of aid commitments allocated by the DAC
donor countries.We consider the effects of six categories
of bilateral aid: total aid, total health-related aid, total
aid to population/reproduction policy and programming,
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Figure 1. Relationship of sample country GDP per capita and maternal mortality, 2015.
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Figure 2.Mean maternal mortality ratio by region, 1995–2015.
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reproductive health aid, family planning aid, and total
aid to maternal and newborn health.1 Figure 3 shows
how the first five of these categories maps onto DAC
aid codes. To account for variation in population size be-
tween countries, we convert these ODA data into per
capita measures. Our analysis uses the log (base 2) of
these measures to account for skewness, meaning that
the coefficients for each measure can be interpreted as
the marginal effect of a doubling of that type of aid.
Our analysis also accounts for other variables that
have an impact on maternal mortality. The other vari-
ables included are Gross Domestic Product (GDP) per
capita, births attended by a skilled birth attendant, ado-
lescent fertility rate, and population using any method
of contraception and the total population. Each of these
variables is drawn from the World Bank’s WDI databank.
To address missing values in this data we replaced miss-
ing data with the most recent year’s non-missing data.
These independent variables are explained below.
GDP per capita: There is a strong negative correlation
between a country’s level of national income and mater-
nal mortality ratio (Bishai et al., 2016). This relationship
has been shown to be robust over time and is evident in
Figure 1. Mean GDP per capita in our sample is $5415. In
ourmodels, GDP per capita ismeasured in constant 2010
US dollars and is logged to account for skewness.
Skilled birth attendant: According to a statement by
WHO, International Confederation of Midwives (ICM),
and the International Federation of Gynecology and
Obstetrics (FIGO), the term ‘skilled attendant’ refers to:
An accredited health professional—such as midwife,
doctor or nurse—who has been educated and trained
to proficiency in the skills needed to manage normal
(uncomplicated) pregnancies, childbirth and the im-
mediate postnatal period, and in the identification,
management or referral of complications in women
and newborns. (WHO, ICM, & FIGO, 2004, p. 1)
Traditional birth attendants either trained or not, are ex-
cluded from this category of skilled healthworkers (WHO
et al., 2004 as cited in Nanda, Switlick, & Lule, 2005, p. 9).
This measure reflects the percentage of births attended
by skilled health personnel, with a mean of 72% of births
in countries in our sample over time.
Adolescent fertility rate: The association between
maternalmortality and the age at birth ofmothers iswell-
established in the literature (Conde-Agudelo, Belizan,
& Lammers 2005; Nove, Mathews, Neal, & Camacho,
2014; WHO, 2018). In our models, adolescent fertility is
measured by the rate of births per 1,000 women aged
15–19 years, and averages 72 births per 1,000 women in
our sample.
Modern contraceptive use: We account for contra-
ceptive use in our analysis using a measure of the per-
centage of women ages 15–49 using at least one mod-
Total Family Planning Aid
(DAC Code: 13030)
Total Reproducve Health Care Aid
(DAC Code: 13020)
Total Populaon & Reproducve
Programming/Policy Aid
(DAC Code: sum of 13000 series)
Total Aid
(DAC Code: 1000)
Total Health Aid
(DAC Code: 120 I. 2)
Figure 3. Aid independent variables and corresponding DAC codes.
1 The first five categories correspond to the following DAC Sector Codes in the CRS: Total Aid (1000); Health Total (120 I. 2); Total Population and
Reproductive Programming and Policy (total of 13000s); Reproductive Health Care (13020); and Family Planning (13030). The final category, total
aid to maternal and newborn health, is drawn from the ODA plus dataset presented in Grollman et al. (2017).
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ern form of birth control. In our models we use this mea-
sure to serve as a proxy measure of reproductive health
services and women’s empowerment (WHO, 2011). The
mean of modern birth control use in our sample is ap-
proximately 34%.
3.2. Analysis
We use a two-way fixed effects panel regression model
with both year- and country-fixed effects to analyze the
impact of foreign aid on maternal mortality. Including
both fixed effects components in ourmodels allows us to
account for the influence of correlation within countries
over time and the effect of global time trends on mater-
nal mortality ratios and all other co-variates. As a result,
our models help us predict the effect of aid on change in
MMR within countries over time and control for all time-
invariant characteristics of a given country. We lag all of
our independent measures one-year behind the depen-
dent variable to allow for a temporal gap in which the
effects of aidmight take hold.2 For example, in our analy-
sis we are predicting the effects of all independent mea-
sures in 2000 onMMR in 2001, or the effects of indepen-
dent variables in 1996 on MMR in 1997. Finally, we run
separate sets of nested models for each of the four aid
measures because they are too highly correlated to pro-
vide meaningful results if included in a single model.
4. Results
We ran a series of nested models for each aid measure,
but in Table 2 we present only the full models for each
for the sake of parsimony. Each model includes one of
our aidmeasures, aswell as the controls for country-level
characteristics. Each of the aid measures is negatively as-
sociatedwithMMRs, but in the case of the Total Aidmea-
sure we fail to reject the null hypothesis. The results rep-
resent the effect of a doubling of a given type of aid. The
strongest effects are seen in total maternal and newborn
health aid (from the ODA plus source) and in ODA com-
mitted under the reproductive health category, where a
doubling predicts amore than 33 death reduction and 26
Table 2. Two-way fixed effects panel regression of maternal mortality on total foreign aid, 1996–2015.
(1) (2) (3) (4) (5) (6)
Aid measures (logged)
Total aid −1.34
Total aid to health −7.12***
Aid to reproductive health −26.07***
Aid to family planning −13.10*
Total aid to population/reproductive −16.41***
policy and programming
Total Maternal and Newborn Health −33.46***
Aid (ODA plus dataset)
Controls
Logged GDP per capita, −42.31*** −42.83*** −44.84*** −41.72*** −43.74*** −47.16***
(constant 2010 USD)
Births attended by skilled health −1.06*** −1.08*** −0.93*** −1.04*** −1.10*** −1.03***
personnel, percentage, percent
Adolescent fertility rate (births per 3.66*** 3.63*** 3.53*** 3.59*** 3.44*** 3.41***
1,000 women ages 15–19)
Contraceptive prevalence, modern −1.89*** −1.86*** −1.83*** −1.89*** −1.55*** −1.77***
methods (percent of women
ages 15–49)
Constant 649.76*** 661.10*** 679.78*** 644.47*** 683.94*** 716.45***
Observations 2093 2093 2093 2093 2093 2093
Countries 130 130 130 130 130 130
R-Squared 0.70 0.70 0.69 0.70 0.69 0.70
Country FE yes yes yes yes yes yes
Year FE yes yes yes yes yes yes
Notes: * p < 0.05, *** p < 0.001.
2 We also tested 2-, 3-, 4-, and 5-year lags and the results were comparable except in the case of one aid measure. Due to the nature of our dataset, the
one-year lag maximizes our sample size.
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death reduction in MMR respectively. These marginal ef-
fects are shown in Figure 4, and indicate that, apart from
total aid’s non-significant relationship to MMR, the most
modest effect on MMR is for total health aid. Increases
in family planning aid and total population/reproductive
policy aid also predict reduced MMR.
Our controls for country and society characteristics
are all correlated with MMRs at the p < 0.001 level.
A doubling of GDP per capita predicts the sharpest reduc-
tion inMMR in allmodels, whilemoremodest reductions
in MMR are associated with increased rates of birth at-
tendance by skilled health professionals and contracep-
tive prevalence. In contrast, adolescent fertility rates are
associated with increases in MMR in all models. The re-
sults of these models show that countries with growing
economies, improving health systems,more readily avail-
able contraception, and decreasing teen birth rates all
stand to see reductions in their national MMR over time.
When comparing our main results to those in our
robustness checks included in the appendix, we note
two differences worth discussing. First, with the change
in sample introduced via the instruments in the instru-
mental variable analysis (see Appendix Table A1), via the
longer lag period (see Appendix Table A2), or via the
use of the IHME MMR data which is restricted to the
1996–2011 period, the robustness of our estimate for
the effect of family planning related aid on MMR is chal-
lenged. In each of the robustness check models, we see
that the family planning aid parameters no longer allow
us to reject the null hypothesis. The second difference,
seen in Tables A1 and A3, are that with the shorter time-
frame and alternate specifications, the total effect of aid
on MMR does meet the p < 0.05 level in our robustness
checks, suggesting that overall aid is correlated with re-
ductions in MMR.
4.1. Robustness Checks
We also conducted a set robustness check models us-
ing: (1) instrumental variable models; (2) instrumental
variable regressions with five-year averaged aid flows;
(3) five different lag periods for our independent vari-
ables; and (4) the alternative measure of MMR from
the IHME. Our first robustness check was to reana-
lyze our data using an instrumental variable approach
(see Appendix, Table A1). Following Dreher and Langlotz
(2017) and Doucouliagos, Hennessy, and Mallick (2019),
we use an excludable instrument based upon the frac-
tionalization of governments in donor countries inter-
acted with the probability of recipient countries receiv-
ing aid in a given year. We construct this instrumentmea-
sure using a dyadic donor-recipient aid dataset based on
OECD figures used in Swiss and Longhofer (2016). Be-
cause foreign aid levels are endogenous to some mea-
sures of development and the other independent vari-
ables in ourmodel, we control for endogeneity by using a
two-stage approach in our instrumental variable models.
In a zero-stage regression, we use OLS to regress
our various aid measures on a lag of each aid measure
and the five-year lag of donor government fractionaliza-
–40 –30 –20
Eﬀect on Maternal Mortality Rao
Logged Total aid (constant 2011 USD)
Logged Total aid to Health
 (constant 2011 USD)
Logged Total aid to reproducve Health
 (constant 2011 USD)
Logged Total aid to family planning
 (constant 2011 USD)
Logged Total populaon/reproducve
policy and programming (OECD)
Logged Total Maternal and Newborn
Health Aid (OCDA plus dataset)
–10 0
Figure 4.Marginal effect of logged aid on maternal mortality with 95% confidence intervals.
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tion interacted with the probability of the recipient coun-
try receiving aid from all donors. Because aid levels are
closely linked to government competition within donor
states (Dreher & Langlotz, 2017), this instrument the
level of global aid is fluctuates independently of the con-
ditions in recipient countries. Following this zero-stage
model, we predict a fitted aid measure that serves as the
excludable instrument in the first-stage model. By inter-
acting the mean donor fractionalization with the mean
probability of each recipient country to receive aid from
all donors in a given year, the instrument remains exoge-
nous to the MMR variable in the second stage.
In the two-stage IV regression, the aid measure is in-
strumented on the fitted aid predicted in the zero-stage
models. The IV models also include year and country
fixed-effects. The results of the IV models in Table A1
show a similar pattern to our main results below.
The second robustness check tested an alternate
specification of our aid measures using a five-year mov-
ing average (see Appendix, Table A2). These results are
consistent with our main analysis, but with the five-year
averages, each of the predicted aid measures is associ-
ated with reductions in maternal mortality.
Our third robustness check tested the effect of dif-
ferent lag periods between our dependent and indepen-
dent variables (see Appendix, Table A2). These results
are consistent with our main analysis, but with a longer
lag period, the predicted effects of family planning aid
no longer attain p-values below the commonly accepted
0.5 threshold.
Our final robustness check was to repeat our analy-
sis using the alternative MMRmeasure discussed earlier
(see Appendix, Table A3). These results closely echo our
main analysis but, as in the case of Table A1, there are
some minor differences of note.
5. Discussion
Our findings show clearly that aid—depending on the
sector in which it is spent—has the potential to help re-
duce maternal mortality. As Figure 3 highlights, the ef-
fects of reproductive health-focused aid or aid targeted
specifically at maternal health are stronger than that of
total aid or total health aid. Given the narrowed focus of
reproductive health-focused aid, it is not unexpected it
might reduce maternal mortality more directly. If, for in-
stance, reproductive health aid is specifically channeled
to the promotion of prenatal and postnatal care includ-
ing deliveries (which are crucial in elements in the re-
duction of maternal mortality), an increase in reproduc-
tive health aid will have a greater likelihood of diminish-
ing MMR.
With an equally narrow focus as reproductive health-
related aid, what might explain the counterintuitive find-
ing we see in the mixed effects of family planning-
focused aid between our main analysis and the robust-
ness checks? Comparing the relationship between repro-
ductive health aid and family planning aid in Figure 5 re-
veals relatively low correlation between the two types
of aid (Pearson’s R of 0.28 in our sample). This suggests
that the same countries receiving significant amounts of
reproductive health aid are not necessarily also in receipt
of family planning aid and vice versa. Likewise, the bivari-
ate relationship of family planning aid to each of adoles-
cent fertility, birth control, and MMR reveal very low lev-
els of correlation < 0.1 in each case. This implies that,
regardless of the intent of family planning-related aid to
make contraceptives more widely available, these pro-
grams are not necessarily associatedwith reducingMMR
either directly or indirectly through reduced fertility or
contraceptive use. Cleland et al. (2006) suggest that un-
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Figure 5. Scatterplot of per capita family planning vs. reproductive health-related aid, sample countries 1996–2014.
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even and at times inconsistent uptake of the most effec-
tive contraceptive methods, erosion of donor and gov-
ernment support for family planning, and the realloca-
tion of funds towards HIV/AIDS programming are all fac-
tors in the reduced efficacy of family planning programs
in recent years. Given these challenges, it is not, perhaps,
surprising that our results reveal an association between
family planning aid that is inconsistent. If family planning
programs are increasingly limited, have less political sup-
port, and are being sidetracked by resources reallocated
to other priorities, it is not unimaginable that they might
not reduce maternal mortality.
In contrast to the narrower focus of reproductive
health aid and aid to maternal health, our main analysis
shows that total aid has no statistically significant effect
on maternal mortality once other factors are controlled
for. This may be due to the fact that the entirety of a
country’s ODA is expansive, and the amount allocated
for maternal health is marginal. This is clear in our sam-
ple, where the mean level of total aid was $68.66 per
capita, while mean aid focused on reproductive health
amounted to only slightly less than half a percent of that
amount at $0.34 per capita. It is not surprising, then,
that total aid might not contribute directly to reductions
in maternal mortality. Indeed, as has been indicated in
much research, MMRs tend not to influence the amount
of aid that is allocated to the health sector, whereas,
in the case of HIV/AIDS, prevalence rates are closely
linked to the amount of foreign funding for HIV/AIDS
programs (Shiffman, 2006; Youde, 2010). It is as a result
of the threat of the disease globally, which donors be-
lieve may be a threat to their own citizens and, there-
fore, to commit more resources to reduce the preva-
lence rates (Shiffman, 2006). A report from the OECD
indicates that between 2006 and 2007, the amount of
health-related aid allocated for HIV/AIDs programs con-
stituted 39% as compared to 13% of aid allocated to the
reproductive health sector (OECD, 2008). Maternal mor-
tality may have seized the attention of the international
aid community, but it is clear that, even with efforts like
the Muskoka Initiative and the SDGs, funding perhaps
does not yet match the development challenges posed
by maternal mortality.
Our other results are in keeping with what is known
about maternal mortality. Each factor shows the type of
associationwithMMR thatwewould expect to see based
on the research literature on maternal mortality. In our
main analysis higher rates of adolescent fertility are asso-
ciated with higher rates of maternal death. Likewise, our
findings show that increasing access to modern meth-
ods of contraception reduces maternal mortality. The re-
sults of this study are consistent with Ahmed, Li, Liu and
Tsui (2012) study which found that increased access to
contraception in countries with low prevalence of con-
traceptive use averted 272,040 maternal deaths. This is
because people can make choices regarding their repro-
ductive health issues andwill also avoid unintended preg-
nancies and to space the number of children they have.
Women with high parity are more likely to have high ma-
ternal mortality as compared to women who have timed
and spaced their children. In addition, contraceptives
lower the risk of unwanted and unintended pregnancies
which often lead to abortion, considered to be the lead-
ing cause of maternal mortality in most developed coun-
tries (Haddad & Nour, 2009; Okonofua, 2006; Rosmans
& Graham, 2006). Despite our potentially contradictory
finding regarding the impact of family planning related
aid funds, the effects of birth control use suggest it may
well remain important to ensure that donor assistance
is channeled towards the provision of contraceptives as
it is a substantial and effective strategy of reducing ma-
ternal mortality in developing countries. Cleland et al.’s
(2006) argument that family planning receives more in-
ternational priority within the context of the SDG post-
2015 might be worth heeding in this case.
6. Conclusion
Since total aid is overly broad, there is insufficient ev-
idence to suggest that overall ODA levels lead to a re-
duction in maternal mortality. However, once aid is
targeted at the health sector generally, and at repro-
ductive health, population programming, and maternal
health more specifically, there is likely to be acceler-
ated progress towards the achievement of the SDG tar-
get for maternal mortality. Still, despite increased efforts
under Muskoka, there is a need to increase more re-
sources not only to the health sector but in a more tar-
geted way towards maternal health. Our results show
that, despite the potential inefficacy of family planning-
focused aid programs, access to contraceptives has a sig-
nificant effect on the reduction of maternal mortality. It
would, therefore, be important to channel more donor
assistance to the promotion of contraceptive use among
women as it serves as a tool to empower them and to
take decisions that influence their reproductive behavior.
One limitation of this study was that it only analyzed
bilateral ODA from the DAC donors and did not capture
multilateral aid or aid from other non-traditional donors
such as theWHO, NGOs, private foundations, businesses,
among others. By tracking the amount committed from
these other donors, a clearer picture of the effects of
donor assistance on maternal mortality might emerge.
Future research should track the amount of resources
from the other donors not reported by the DAC so that
the true effect of foreign assistance on maternal health
could be established. Research is also needed to do a
comparison between the DAC and the non-traditional
donors to compare the behavior of these groups of
donors and their impact on maternal mortality.
A second limitation of this study is that it does a cross-
country analysis of donor funding to various countries
and the results may not be in context for all countries.
A possible extension of this study could focus on indi-
vidual countries and the amount of donor assistance re-
ceived respectively, with more attention paid to what
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services, expertise, and reforms aid money is actually
funding. Likewise, multilevel models studying the mater-
nal health outcomes of individuals nested in national con-
texts could help deepen our understanding of the effects
of aid further. A detailed case study of individual coun-
try is necessary in order to establish a more nuanced
picture of the effect of foreign aid on maternal mortal-
ity. Donor decisions on the level of maternal health assis-
tance provided, the nature of those programs, and how
they are implemented in individual countries likely vary
widely and it would be important to treat each country
as a unique case.
The results of this study should be interpreted with
caution since the data on the DAC reporting system bro-
ken down at the sector level are commitments from the
donor community rather than actual disbursements, so
actual aid flows to each country might depart signifi-
cantly from what donors committed. Still, given these
data limitations, our study is one of the first to clarify the
relationship between aid and maternal mortality over
time, and makes a contribution to both the research lit-
erature on maternal mortality specifically, and to the lit-
erature on the effects of aid more generally.
TheMuskoka Initiative in 2010 drew significant donor
attention to the issue of maternal mortality and encour-
aged an intensification of efforts towards supporting re-
cipient countries in achieving MDG 5 and reducing the
burden of maternal mortality. These efforts now con-
tinue under the SDG framework of the 2030 Agenda. Our
results suggest that this international agenda-setting ex-
ercise is not without merit. Foreign aid narrowly focused
on issues of reproductive andmaternal health is strongly
associated with declining maternal mortality. As the im-
plementation of Agenda 2030 unfolds, these results sug-
gest that the international community would do well to
continue to invest its development assistance resources
in ongoing efforts to counter maternal mortality wher-
ever it remains a significant threat to women’s lives.
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Appendix
Table A1. Instrumental variable two-stage fixed effects regression of maternal mortality on foreign aid, 1996–2014.
(1) (2) (3) (4) (5) (6)
Second stage regression results (two-way fe)
Aid measures (logged)
Total aid −4.41
Total aid to health −54.28**
Aid to reproductive health −104.97***
Aid to family planning −10.08
Total aid to population/reproductive policy −54.73***
Total MNH Aid (ODA plus dataset) −76.65***
Observations 2054 2054 2054 2054 2054 2054
Countries 128 128 128 128 128 128
R-Squared 0.50 0.30 0.39 0.51 0.42 0.49
Controls yes yes yes yes yes yes
Country FE yes yes yes yes yes yes
Year FE yes yes yes yes yes yes
Cragg-Donald Weak Identification 617.45 24.72 79.90 334.66 164.92 609.00
Anderson Underidentification Test 471.83 24.69 77.60 288.05 153.60 466.93
First stage regression results (two-way fe)
Fitted aid (correspond to aid measures above) 0.52*** 0.15*** 0.34*** 0.54*** 0.34*** 0.68***
Observations 2054 2054 2054 2054 2054 2054
Countries 128 128 128 128 128 128
R-Squared 0.30 0.10 0.13 0.23 0.29 0.60
Controls yes yes yes yes yes yes
Country FE yes yes yes yes yes yes
Year FE yes yes yes yes yes yes
Zero order regression results (OLS)
One-year lagged aid measure 0.93*** 0.73*** 0.59*** 0.67*** 0.81*** 0.76***
Donor fractionalization-aid receipt probability 0.58** 0.89*** 0.44*** 0.28*** 0.69*** 0.10
Observations 2054 2054 2054 2054 2054 2054
Countries 128 128 128 128 128 128
R-Squared 0.88 0.54 0.36 0.48 0.65 0.59
Controls no no no no no no
Country FE no no no no no no
Year FE no no no no no no
Notes: * p < 0.05, ** p < 0.01, *** p < 0.001. The donor fractionalization-aid receipt probability measures in the zero order regression
is the interaction of the mean donor-state government fractionalization (World Bank DPI) for all donors in a given recipient country and
the mean probability of a recipient country to receive any aid from all possible donors in the Swiss and Longhofer (2016) dataset. The
interaction term is lagged five years to account for the aid project cycle, providing time for changes in donor governments and aid levels
to take effect.
Politics and Governance, 2019, Volume 7, Issue 2, Pages 53–67 65
Table A2. Two-way fixed effects panel regression of maternal mortality on five-year average foreign aid flows, 1999–2015.
(1) (2) (3) (4) (5) (6)
Aid measures (logged five-year average)
Total aid −6.54**
Total aid to health −18.09***
Aid to reproductive health −47.97***
Aid to family planning −17.96*
Total aid to population/reproductive policy −27.04***
Total MNH Aid (ODA plus dataset) −45.58***
Observations 1919 1919 1919 1919 1919 1919
Countries 130 130 130 130 130 130
R-Squared 0.68 0.68 0.67 0.68 0.66 0.68
Controls yes yes yes yes yes yes
Country FE yes yes yes yes yes yes
Year FE yes yes yes yes yes yes
Notes: * p < 0.05, ** p < 0.01, *** p < 0.001.
Table A3. Two-way fixed effects panel regression of maternal mortality on foreign aid, different lags.
(1) (2) (3) (4) (5)
1-year lag 2-year lag 3-year lag 4-year lag 5-year lag
Aid measures (logged)
Total aid −1.34 −1.85 −1.85 −1.83 −1.57
Total aid to health −7.12*** −5.37*** −5.52*** −5.59*** −4.65***
Aid to reproductive health −26.07*** −23.78*** −21.58*** −17.42*** −17.10***
Aid to family planning −13.10* −9.76* −2.82 −0.24 3.12
Total aid to population/reproductive policy −16.41*** −16.72*** −16.25*** −15.44*** −14.90***
Total MNH Aid (ODA plus dataset) −33.46*** −38.67*** −35.04*** −30.73*** −26.81***
Observations 2093 1965 1837 1709 1582
Countries 130 130 130 128 127
Controls yes yes yes yes yes
Country FE yes yes yes yes yes
Year FE yes yes yes yes yes
Notes: * p < 0.05, *** p < 0.001.
Table A4. Two-way fixed effects panel regression of MMR on foreign aid, 1996–2011, (IHME MMR measure).
(1) (2) (3) (4) (5) (6)
Aid measures (logged)
Total aid −13.79***
Total aid to health −13.64***
Aid to reproductive health −28.30***
Aid to family planning 3.33
Total aid to population/reproductive policy −45.16***
Total MNH Aid (ODA plus dataset) −23.18**
Observations 1582 1582 1582 1582 1582 1582
Countries 127 127 127 127 127 127
R-Squared 0.06 0.11 0.07 0.11 0.02 0.08
Controls yes yes yes yes yes yes
Country FE yes yes yes yes yes yes
Year FE yes yes yes yes yes yes
Notes: ** p < 0.01, *** p < 0.001.
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